Annual and Sustainability Report 2022
On April 13, 2023 CellaVision published its Annual and Sustainability Report for 2022. The report is available under Reports & presentations.
Questions? We're here to help
CellaVision in brief
About 20 years ago, CellaVision introduced automation and digital imaging to cell morphology, thereby creating what today is known as Digital Cell Morphology. Today, we offer a family of products that form a unique and flexible automation concept that helps Laboratory Managers address the key challenges associated with morphological cell analysis.
The CellaVision share has been listed on the NASDAQ Stockholm, Mid Cap since 2018. Learn more about the CellaVision share here.
CellaVision is committed to the corporate governance principles to promote business competitiveness and investor confidence.
We help hematology laboratories automate and simplify the process of performing blood and body fluid differentials.